A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe.

Body, Jean-Jacques; von Moos, Roger; Rider, Alex; Hallworth, Pamela; Bhowmik, Debajyoti; Gatta, Francesca; Hechmati, Guy; Qian, Yi

Body, Jean-Jacques; von Moos, Roger; Rider, Alex; Hallworth, Pamela; Bhowmik, Debajyoti; Gatta, Francesca; Hechmati, Guy; Qian, Yi.

Afiliação

Body JJ; Department of Medicine, CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
von Moos R; Kantonsspital Graubünden, Chur, Switzerland.
Rider A; Adelphi Real World, Bollington, UK.
Hallworth P; Adelphi Real World, Bollington, UK.
Bhowmik D; Amgen Inc., Thousand Oaks, CA, USA.
Gatta F; Amgen (Europe) GmbH, Risch-Rotkreuz, Switzerland.
Hechmati G; Amgen Inc., Thousand Oaks, CA, USA.
Qian Y; Amgen Inc., Thousand Oaks, CA, USA.

J Bone Oncol ; 14: 100212, 2019 Feb.

Article em En | MEDLINE | ID: mdl-30627511

Palavras-chave

AAP, abiraterone acetate with prednisone/prednisolone; AQA, Analgesic Quantification Algorithm; BMs, bone metastases; BPI, Brief Pain Inventory; BTA, bone-targeted agent; Bone metastases; Bone pain; Bone-targeted agents; DSP, Disease Specific Programme; EQ-5D-3L, 5-dimension 3-level EuroQol questionnaire; EU5, France, Germany, Italy, Spain and the UK; FACT-P, Functional Assessment of Cancer Therapy Prostate questionnaire; ONJ, osteonecrosis of the jaw; PRF, Patient Record Form; PRO, patient-reported outcome; PSCF, Patient Self-Completion Form; QoL, quality of life; SRE, skeletal-related event; mCRPC, metastatic castration-resistant prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2019 Tipo de documento: Article